CLASS II Drug recall · Reported 3 Jan 2018 · FDA Enforcement Report
Amiodarone 900 mg in dextrose 5%, Concentration: 1.8 mg/mL recalled
SSM Health Care St. Louis is recalling Amiodarone 900 mg in dextrose 5%, Concentration: 1.8 mg/mL, This is a compounded, distributed in Missouri. The recall was initiated on 10 Aug 2017 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0137-2018
- FDA event ID
- 78678
- Recalling firm
- SSM Health Care St. Louis, Fenton, MO
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- 10 Aug 2017
- FDA classified
- 28 Dec 2017
- Reported
- 3 Jan 2018
- Type
- Voluntary: Firm initiated
- Customers notified by
- Reason category
- Sterility
- Drug class
- Injectable & IV Drugs
Timeline
| 10 Aug 2017 | Recall initiated by company | |
| 28 Dec 2017 | Classified by FDA | +140 days |
| 3 Jan 2018 | Published in enforcement report | +6 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Lack of sterility assurance: Microbial growth detected during a routine simulation of the manufacturing process. No batches of distributed product have been identified as actually containing microorganisms.
A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.
Product as listed by the FDA
Amiodarone 900 mg in dextrose 5% 500 mL, 500 mL bag, Concentration: 1.8 mg/mL, This is a compounded injectable drug; Rx only; Hospital/office use only. SSM St. Clare Outsourcing Facility, Fenton, MO. --- NDC: 88890-0333-01
Where it was distributed
SSM Health entities in the state of MO only
Questions about this recall
Why was it recalled?
Lack of sterility assurance: Microbial growth detected during a routine simulation of the manufacturing process. No batches of distributed product have been identified as actually containing microorganisms.
Which lots are affected?
Lot: 170711-005, 10/09/2017
Where was it sold?
SSM Health entities in the state of MO only
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
Other products in this recall event
9 other products · FDA event 78678This product is part of a recall event; the main page for the event is Norepinephrine 8 mg in dextrose 5% IV, Concentration recalled.
More recalls from SSM Health Care St. Louis
All 14Other Amiodarone recalls
All 8| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Nexterone (amiodarone HCI), 360 mg/ (1.8 mg/mL) recalledNexterone | Baxter Healthcare | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS I | Amiodarone Hydrochloride Injection, USP, 450 mg recalledAmiodarone Hydrochloride | Mylan Institutional | Packaging Defects | Nationwide |
| Drug | CLASS III | Amiodarone Hydrochloride Injection, USP, 900 mg recalledAmiodarone Hydrochloride | AuroMedics Pharma | Particulate Matter | Nationwide |
| Drug | CLASS III | Amiodarone Hydrochloride Injection, USP, 450 mg recalledAmiodarone Hydrochloride | AuroMedics Pharma | Particulate Matter | Nationwide |
| Drug | CLASS III | Amiodarone Hydrochloride Injection, USP, 150 mg recalledAmiodarone Hydrochloride | AuroMedics Pharma | Particulate Matter | Nationwide |